170229-98-8

Usage

Uses

Used in Pharmaceutical Industry:
4-Bromo-3-methylbenzamide is used as a key intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs and treatments. Its ability to act as a building block in the creation of more complex organic molecules makes it a valuable component in medicinal chemistry.
Used in Research and Development:
In the pharmaceutical industry, 4-Bromo-3-methylbenzamide is utilized in research and development to explore its potential applications and properties, furthering the understanding of its role in drug discovery and synthesis.
Used in Agrochemical Production:
4-Bromo-3-methylbenzamide is also employed in the production of agrochemicals, where it serves as an intermediate in the synthesis of compounds used in agriculture to protect crops and enhance yields.
Used in Specialty Chemicals Production:
4-BROMO-3-METHYLBENZAMIDE finds application in the production of specialty chemicals, where its unique properties are harnessed to create tailored products for specific industries, such as coatings, adhesives, or materials science.

InChI:InChI=1/C8H8BrNO/c1-5-4-6(8(10)11)2-3-7(5)9/h2-4H,1H3,(H2,10,11)

Upstream product

• 1336-21-6 ammonium hydroxide 
• 79-37-8 oxalyl dichloride 
• 7697-28-1 4-bromo-3-methylbenzoic acid 
• 41963-20-6 4-bromo-3-methylbenzonirtile 
• 75-24-1 trimethylaluminum 

Downstream Products

• 157672-20-3 2-(4-bromo-3-methylphenyl)oxazole 
• 149104-92-7 (4-bromo-3-methyl-phenyl)methanamine 
• 631911-09-6 3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide 
• 41963-20-6 4-bromo-3-methylbenzonirtile 
• 1108613-19-9 5-(4-Carbamoyl-2-methyl-phenylethynyl)-2-trifluoromethoxy-benzoic acid 
• 176961-42-5 2-[4-Bromo-3-(bromomethyl)-phenyl]oxazole 
• 176961-43-6 2-[4-Bromo-3-(formyl)phenyl]oxazole 
• 1008736-37-5 4-aminomethyl-2-methyl-benzonitrile 

Relevant academic research and scientific papers

As opioid receptor antagonists or inverse agonists of the novel compounds

Novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, pharmaceutical compositions containing them, to processes for their preparation.

Synthesis and structure-activity relationships of novel benzoxaboroles as a new class of antimalarial agents

A series of boron-containing benzoxaborole compounds was designed and synthesized for a structure-activity relationship investigation surrounding 7-(HOOCCH2CH2)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (1) with the goal of discovering

SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS

Compounds of Formula I: and salts thereof in which R1, R2, R2a, R3, n, X and ring B have the meanings given in the specification, are inhibitors of mTOR and are useful in the treatment of diseases which are sensitive to inhibition of mTOR, such as cancers.

SUBSTITUTED BIPHENYL SULFONAMIDE ENDOTHELIN ANTAGONISTS

Compounds of the formula STR1 inhibit the activity of endothelin.

SUBSTITUTED BIPHENYL ISOXAZOLE SULFONAMIDES

Compounds of the formula STR1 inhibit the activity of endothelin. The symbols are defined as follows: R 1, R 2, R 3 and R 4 are each directly bonded to a ring carbon and are each independently(a) hydrogen;(b) alkyl, alkenyl, alkynyl, alkoxy,